Path ID: DB00668_MESH_D005902_1

Concepts
Identifier | Name | Type |
---|---|---|
MESH:D004837 | epinephrine | Drug |
UniProt:P35348 | Alpha-1A adrenergic receptor | Protein |
UniProt:P35368 | Alpha-1B adrenergic receptor | Protein |
UniProt:P25100 | Alpha-1D adrenergic receptor | Protein |
reactome:R-HSA-416476 | G alpha (q) signalling events | Pathway |
reactome:R-HSA-416482 | G alpha (12/13) signalling events | Pathway |
GO:0042310 | vasoconstriction | BiologicalProcess |
UBERON:0001796 | aqueous humor of eyeball | GrossAnatomicalStructure |
HP:0007906 | Ocular Hypertension | PhenotypicFeature |
MESH:D005902 | Open-angle glaucoma | Disease |
Relationships
NOTE: predicates are annotated in Biolink Model (v1.3.0)
Subject | Predicate | Object |
---|---|---|
Epinephrine | INCREASES ACTIVITY OF | Alpha-1A Adrenergic Receptor |
Epinephrine | INCREASES ACTIVITY OF | Alpha-1B Adrenergic Receptor |
Epinephrine | INCREASES ACTIVITY OF | Alpha-1D Adrenergic Receptor |
Alpha-1D Adrenergic Receptor | PARTICIPATES IN | G Alpha (Q) Signalling Events |
Alpha-1A Adrenergic Receptor | PARTICIPATES IN | G Alpha (Q) Signalling Events |
Alpha-1B Adrenergic Receptor | PARTICIPATES IN | G Alpha (Q) Signalling Events |
Alpha-1D Adrenergic Receptor | PARTICIPATES IN | G Alpha (12/13) Signalling Events |
Alpha-1A Adrenergic Receptor | PARTICIPATES IN | G Alpha (12/13) Signalling Events |
Alpha-1B Adrenergic Receptor | PARTICIPATES IN | G Alpha (12/13) Signalling Events |
G Alpha (Q) Signalling Events | POSITIVELY REGULATES | Vasoconstriction |
G Alpha (12/13) Signalling Events | POSITIVELY REGULATES | Vasoconstriction |
Vasoconstriction | NEGATIVELY CORRELATED WITH | Aqueous Humor Of Eyeball |
Aqueous Humor Of Eyeball | POSITIVELY CORRELATED WITH | Ocular Hypertension |
Ocular Hypertension | POSITIVELY CORRELATED WITH | Open-Angle Glaucoma |
Comment: DrugBank (https://go.drugbank.com/drugs/DB00668) has this drug modulating beta receptors but not for glaucoma. For this indication, the ligand should be an antagonist (and epinephrine is an agonist instead).
Reference: